Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) SHH

66.65

-1.2(-1.77%)

Updated at February 13 03:00PM

Currency In CNY

Valuation

Market Cap4.23B
Enterprise Value4.08B
P/E Ratio54.76
PEG Ratio-3.61
Price/Sales Ratio7.16
Price/Book Ratio6.27
Enterprise/Revenue7.17
Enterprise/EBITDA55.18

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.13
Operating Margin0.12

Management Effectiveness

Return On Assets0.06
Return On Equity0.12

Income Statement

Revenue1.08B
Revenue/Share9.31
Gross Profit541.14M
EBITDA201.69M
Net Income177.41M
Diluted EPS1.58

Balance Sheet

Total Cash706.41M
Total Cash/Share6.46
Total Debt588.42M
Total Debt/Equity0.51
Current Ratio1.8
Book Value Per Share10.66

Price History

52-Week Change44.36
52-Week High86.5
52-Week Low33
Moving Average 50 Days68.83
Moving Average 200 Days62.76

Statistics

Average Volume3.08M
Shares Outstanding109.28M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.16
Trailing Annual Dividend Yield0.24
Payout Ratio0.25
Last Split Factor7:5
Last Split DateMay 12, 2023